Managers / Q2 2021 · view latest →
Hunter Perkins Capital Management, LLC
CIK 0001808919 · 377 E. BUTTERFIELD ROAD, SUITE 220, LOMBARD, IL, 60148 · 3123419727
Summary
Hunter Perkins Capital Management, LLC reported $537M in U.S.-listed holdings across 85 positions for Q2 2021.
Its largest position, Laboratory Corp Amer, represents 11.0% of the portfolio.
Compared with Q1 2021, the fund opened 5 new positions and exited 4.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 73.5% · $395M
- REIT · 13.8% · $74M
- Other · 11.4% · $61M
- ETP · 0.9% · $5M
- ADR · 0.1% · $706,000
- Other · 0.2% · $1M
Quarter-over-Quarter Changes full breakdown →
vs Q1 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| PBPROSPERITY BANCSHARES INC | NEW | +171.0K | 171.0K | +$12M | $12M |
| LKQLKQ CORP | NEW | +160.3K | 160.3K | +$8M | $8M |
| MUMICRON TECHNOLOGY INC | NEW | +5.0K | 5.0K | +$425,000 | $425,000 |
| PRTAPROTHENA CORP PLC | NEW | +5.8K | 5.8K | +$298,000 | $298,000 |
| ANABANAPTYSBIO INC | NEW | +9.1K | 9.1K | +$237,000 | $237,000 |
| RVSBRIVERVIEW BANCORP INC | ADDED | +45.2K | 62.2K | +$323,000 | $441,000 |
| CSXCSX CORP | ADDED | +24.0K | 36.0K | −$2,000 | $1M |
| USBUS BANCORP DEL | ADDED | +15.1K | 25.1K | +$877,000 | $1M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $427M | 143 | May 12, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $432M | 116 | Jan 14, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $451M | 115 | Oct 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $423M | 110 | Jul 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $431M | 104 | Apr 24, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $476M | 104 | Jan 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $493M | 106 | Oct 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $476M | 107 | Jul 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $488M | 106 | Apr 23, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $479M | 89 | Jan 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $466M | 126 | Oct 19, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $469M | 181 | Jul 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $424M | 113 | Apr 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $444M | 94 | Jan 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $409M | 88 | Oct 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $434M | 83 | Jul 20, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $498M | 83 | Apr 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $533M | 86 | Jan 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $492M | 76 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $537M | 85 | Jul 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $495M | 84 | Apr 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $565M | 174 | Feb 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $387M | 78 | Oct 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $347M | 70 | Jul 20, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.